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Circulating 25-hydroxyvitamin D (25(OH)D), a marker for vitamin D status, is associated with bone health and
possibly cancers and other diseases; yet, the determinants of 25(OH)D status, particularly ultraviolet radiation
(UVR) exposure, are poorly understood. Determinants of 25(OH)D were analyzed in a subcohort of 1,500 partic-
ipants of the US Radiologic Technologists (USRT) Study that included whites (n = 842), blacks (n = 646), and
people of other races/ethnicities (n = 12). Participants were recruited monthly (2008–2009) across age, sex,
race, and ambient UVR level groups. Questionnaires addressing UVR and other exposures were generally com-
pleted within 9 days of blood collection. The relation between potential determinants and 25(OH)D levels was
examined through regression analysis in a random two-thirds sample and validated in the remaining one third. In
the regression model for the full study population, age, race, body mass index, some seasons, hours outdoors
being physically active, and vitamin D supplement use were associated with 25(OH)D levels. In whites, general-
ly, the same factors were explanatory. In blacks, only age and vitamin D supplement use predicted 25(OH)D
concentrations. In the full population, determinants accounted for 25% of circulating 25(OH)D variability, with
similar correlations for subgroups. Despite detailed data on UVR and other factors near the time of blood collec-
tion, the ability to explain 25(OH)D was modest.
dietary supplements; 25-hydroxyvitamin D; race; seasons; sex; sunlight; ultraviolet rays; vitamin D
Abbreviations: BMI, body mass index; 25(OH)D, 25-hydroxvitamin D; TOMS, Total Ozone Mapping Spectrometer; USRT,
United States Radiologic Technologists; UVR, ultraviolet radiation.
Vitamin D plays an established protective role in bone
development and health (1–4) and may inﬂuence the risk of
other major diseases, including some cancers, cardiovascu-
lar disease, autoimmune conditions, and diabetes (1).
Because of the known and potential beneﬁts of vitamin D,
there is considerable interest in understanding the determi-
nants of vitamin D status (1, 5–7).
Circulating 25-hydroxyvitamin D (25(OH)D) is consid-
ered a marker for vitamin D status (8). A key source of cir-
culating 25(OH)D is thought to be ultraviolet radiation
(UVR), which interacts with cutaneous 7-dehydrocholester-
ol; casual UVR exposure reportedly accounts for as much
as 90% of vitamin D requirements (9). Other sources
include dietary and supplemental vitamin D intake (8). Un-
derstanding how various demographic, dietary, behavioral,
and environmental factors contribute to 25(OH)D levels
could help identify individuals at risk of low status, as well
as facilitate modeling of circulating 25(OH)D, which could
be less costly than assaying vitamin D for epidemiologic
studies.
Investigators in many studies have examined the poten-
tial determinants of 25(OH)D variability in different popu-
lations (10–41). Very few studies, however, have been
designed to examine factors within the relevant time
period, especially regarding the key determinant, personal
UVR exposure. Circulating 25(OH)D is thought to have a
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half-life measured in weeks (8, 42, 43), but many studies
do not have data on individual UVR exposure just before
blood collection (11, 17, 25, 27, 30, 34). Instead, studies
have often relied on geographic indicators of UVR (e.g.,
latitude, regional residence) (11, 17, 25, 27, 30) that are
neither individually speciﬁc nor close to the date of blood
collection for the measurement of vitamin D. Many studies
also do not inquire about food and supplement intake
during the period immediately preceding the blood draw
(11, 21, 25). In addition, numerous studies examined
single-sex (12–15, 18, 24, 27, 30) or largely white (11–13,
15, 19, 20, 24, 28) populations, so limited data are avail-
able on differences by sex and race.
In the present study, we examined personal UVR expo-
sure and other potential determinants of circulating 25(OH)D
within the US Radiologic Technologists (USRT) Study.
The study population selected was geographically diverse
and included both sexes, as well as substantial numbers of
whites and blacks, and the study was designed to identify
determinants close to the date circulating 25(OH)D was
measured.
MATERIALS AND METHODS
The USRT Study, which began in 1983, comprises a na-
tionwide cohort of US radiological technologists who were
certiﬁed by the American Registry of Radiological Tech-
nologists during 1926–1980 (44). The USRT Study has
been approved annually by the human subjects review
boards at the University of Minnesota and the National
Cancer Institute, and all participants provided written in-
formed consent.
Study population
We targeted participants from a random sample of
10,752 technologists (representative group recruited for
multiple purposes) that was enriched by inclusion of all
blacks who were not in the random sample (supplementary
group, n = 2,593) because the black technologists constitute
a small percentage of the USRT Study population. Of
these, 9,141 technologists from the representative group
and 2,374 from the supplementary group were eligible
because they were still living and had not previously
refused blood collections.
Participants were approached for blood collection and
questionnaire administration between August 2008 and De-
cember 2009. Each month, random samples from the repre-
sentative and supplementary groups were selected within
strata deﬁned by sex, age, and ambient UVR exposure and
asked to participate in the study. Ambient UVR (erythemal)
exposure estimates were derived from linking participants’
residences to the Total Ozone Mapping Spectrometer
(TOMS) database (45). A total of 4,321 respondents (3,707
from the representative group and 614 from the supplemen-
tary group) provided blood samples and self-administered
surveys for this and other studies (Table 1). Among
persons eligible for the study, participation rates were 41%
in the representative sample and 26% in the sample of black
participants. We also recruited a subset of participants
(from each of the 2 groups) to provide a second sample
approximately 6 months later to examine changes in
vitamin D levels over time, which is the subject of another
article (46).
Because of limited resources, 25(OH)D assays were per-
formed on a subset of 2,038 samples from 1,500 individu-
als, which included samples from participants who had
provided 2 samples and single samples from white and
black participants who provided blood within 9 days of
questionnaire completion (Table 1). We restricted the time
between the blood collection and questionnaire to 9 days to
assure a short time between questionnaire and blood draw.
Of the 1,500 participants, 842 were white, 646 were black,
and 12 were of other races/ethnicities.
Data collection
Each participant was mailed a blood collection kit to-
gether with a questionnaire and asked to complete question-
naires the same day as the blood draws. Questionnaires
were returned to the study ofﬁce and blood samples were
shipped overnight with temperature stabilizing packs to the
processing laboratory in Frederick, Maryland. The ques-
tionnaire, which included 4 pages on potential determinants
of vitamin D status, requested that participants provide
information about behaviors during the past 30 days, as
described below.
Table 1. Distribution of Blood Samples Among 4,321 Participantsa
in the US Radiologic Technologists’ Study of Determinants of
Circulating 25-Hydroxyvitamin D, 2008–2009
Distribution by Racial/
Ethnic Group
No. of Participants
Provided 1
Sample
Provided 2
Samples Total
White (n = 3,530)
Eligible 3,049b 329c
Selected 513d 329 842
Noneligible 152 N/A
Black (n = 691)e
Eligible 449b 197c
Selected 449 197 646
Noneligible 45 N/A
Other (n = 100)
Eligible 81b 12c
Selected 0 12 12
Noneligible 7 N/A
Abbreviation: N/A, not applicable.
a There were 1,500 total participants selected for 25(OH)D
assays.
b Nine or fewer days between blood collection and questionnaire
administration.
c No restrictive criteria.
d Random stratified sample by sex, age group, ambient UVR
region, and season.
e From both reference and supplementary US Radiologic
Technologists’ Study samples.
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Circulating 25(OH)D measurements
The 25(OH)D plasma samples were assayed in 23
batches by Heartland Assays, Inc. (Ames, Iowa) using
CLIA/LIASON in commercially available kits from Dia-
Sorin (Stillwater, Minnesota). We selected quality controls
(5 per batch) from study samples in a run-in to represent
low, medium, and high concentrations, which averaged
42.1 nmol/L, 69.8 nmol/L, and 101.2 nmol/L, respectively.
Quality control samples were randomly distributed across
and within batches by race, sex, geographic UVR region,
and season. The total coefﬁcients of variation were 8.3%,
7.2%, and 5.8%, for low, medium, and high circulating 25
(OH)D, respectively, with an overall average of 7.1%.
Statistical analysis
The following questionnaire-derived variables were con-
sidered as potential determinants of circulating 25(OH)D
Table 2. Means and Proportion of Selected Characteristics, by Racial Groupa, in the US Radiologic
Technologists’ Study, 2008–2009
Characteristic
Whites (n = 842) Blacks (n = 646)
Mean (SD) % Mean (SD) %
25(OH)D, nmol/L 74.2 (28.8) 62.7 (33.3)
Women 51.7 65.8
Age, years 63.5 (9.5) 62.5 (8.1)
Range, years 48.0–93.0 49.0–92.0
Season of blood receiptb
Winter 36.6 24.6
Spring 23.0 23.7
Summer 13.4 24.3
Fall 27.0 27.4
Latitude
<35° 25.4 34.5
35°–42° 48.8 56.2
>42° 25.8 9.3
Quintile of mean annual UVR exposurec
1 23.4 15.8
2 22.1 16.7
3 19.6 20.7
4 19.2 21.1
5 15.7 25.7
Minutes outside per week 84.8 (81.8) 75.5 (74.7)
Long sleeves never or rarely worn outside 18.3 28.0
Dietary intake, IU/day 270.4 (256.7) 365.9 (470.8)
Took supplements 58.9 48.3
Supplement intake, IU/day 523.3 (490.7) 452.8 (482.1)
≥1,000 IU/day 14.3 11.2
Current smoker 9.3 9.6
Body mass indexd 28.2 (5.7) 30.1 (6.3)
Abbreviations: 25(OH)D, 25-hydroxyvitamin D; SD, standard deviation; UVR, ultraviolet radiation.
a Characteristics describe all whites and blacks contributing to the analysis based on first (or only) samples.
“Whites” refers to non-Hispanic whites and “blacks” to non-Hispanic blacks. Twelve participants who were not white
or black are not included in this table. However, all 12 provided 2 samples and are included in the study analyses
presented in subsequent tables.
b The seasons were defined as winter (January–March), spring (April–June), summer (July–September), and
fall (October–December).
c Mean UVR doses were estimated for the month of questionnaire administration based on residential linkage
for the Total Ozone Mapping Spectrometer database, with data averaged from 1978 to 1993. Quintile 1 was lowest;
quintile 5 was highest.
d Weight (kg)/height (m)2.
182 Freedman et al.
Am J Epidemiol. 2013;177(2):180–192
levels: age (continuous); sex; race (white, black, or other
(based on self-classiﬁcation)); season of blood draw
(January–March, April–June, July–September, or October–
December); latitude of residence (continuous); average total
number of hours outdoors each day between sunrise and
sunset; hours outside in time blocks (e.g., 10 AM–2 PM);
percentage of time outside when participant was moderate-
ly/strenuously physically active (0; <25%, 25%–74%,
≥75%); frequency of various protective behaviors (i.e.,
wearing a hat, long-sleeved shirt, or long pants, moving
into shady areas, or wearing sunscreen when in the sun);
sun protection factor if sunscreen was used; number of days
in sun for more than 1 hour if more than 200 miles from
home on a trip; tanning bed use (ever vs. never); complex-
ion (light, medium, or dark); tan levels (comparing inner
upper arm with back of hand); body mass index (BMI;
weight (kg)/height (m2); continuous); current smoking (yes
vs. no); current hormone replacement therapy use (yes vs.
no); and inﬂammatory bowel disease (yes vs. no).
Mean UVR erythemal ambient exposures were estimated
for the month of questionnaire administration based on resi-
dential linkage to the TOMS database, with data from
1978–1993 averaged. The TOMS database, maintained by
the National Aeronautics and Space Administration, pro-
vides daily estimates of ground-level erythemal exposures
(which incorporate part of the UVR spectrum contributing
to 25(OH)D production, particularly UVB) on a 1°-latitude-
by-1.25°-longitude grid.
Dietary intake of vitamin D in international units per day
was calculated based on self-reported consumption of sal-
mon, tuna, fortiﬁed cereal, milk, eggs, margarine, and forti-
ﬁed juice, using frequency and serving size categories, with
international units per food portion derived from the Ofﬁce
of Dietary Supplements Fact Sheet (47). Vitamin D supple-
ment intake (IU/day) was based on multivitamin, vitamin
D, and cod liver oil consumption (using frequency per
week, reported dose for vitamin D and cod liver oil supple-
ments, and name brands for multivitamins to permit dose
estimates). When the name brands of multivitamins were
not reported or could not be linked to a dose, we imputed a
dose of 400 IU, the most common formulation.
Participant characteristics were analyzed by cutpoints for
circulating 25(OH)D that correspond to very low levels
(<25 nmol/L) (25); alternative thresholds for potential in-
sufﬁciency, 50 nmol/L (1) and 75 nmol/L (48); and a com-
mon upper cutpoint, 100 nmol/L (25). The plot to examine
normality showed a slightly skewed deviation of 25(OH)D
from normality. The Box-Cox procedure (49) suggested
that the square root transformation of 25(OH)D was closer
to a normal distribution. However, because the transformed
and untransformed results were similar, we present the un-
transformed results. We examined each potential determi-
nant using multivariate linear regression adjusted for age,
sex, and race. Analyses were repeated within sex, race, and
season subgroups. Many key variables had no missing data
(e.g., age, race, season, latitude, mean UVR exposure), and
most had less than 5% missing data. Missing information
was included in the model by coding “missing” to separate
dummy variables.
Backwards stepwise linear regression analysis was used
to select determinants in a random sample of two thirds of
the participants (n = 1,000, model construction sample) and
within sex, race, and season subgroups. If a participant pro-
vided 2 samples, the ﬁrst was used. Additional factors en-
tered into the models were season of blood draw, BMI,
ambient UVR quintiles, time outdoors, physically active
time outdoors, frequency of wearing long-sleeved shirts,
dietary intake of vitamin D, supplement intake of vitamin
D, tan level, smoking status, hormone replacement therapy
use, and number of days in the sun away from residence.
We excluded some factors for which a similar factor ex-
plained more variance in the single-factor regression analy-
sis (e.g., total time outdoors vs. time blocks, long sleeves
vs. long pants). The backwards stepwise regression proce-
dure selected variables with 1 or more categorical level
Figure 1. Mean circulating 25-hydroxyvitamin D (25(OH)D)
concentrations by season and latitude in the US Radiologic
Technologists’ Study, 2008–2009. Circles represent mean values
and bars, standard errors for the means. A) 25(OH)D concentrations
in whites (n = 842). B) 25(OH)D concentrations in blacks (n = 646).
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with a P value ≤ 0.05, ﬁxing age, sex, and race to remain
in the model. We applied the resulting beta coefﬁcients to
the remaining one-third validation sample, that is, those not
in the model construction sample (n = 500), and within the
subgroups, then correlated the predicted and actual values
for the validation sample. Because the Pearson correlation
coefﬁcients for the validation sample was reasonably good
(r = 0.50, P < 0.0001), we applied the models developed in
the model construction sample to the full study population
(n = 1,500) and subgroups (27). Aside from age, sex, and
race, which were ﬁxed in all models, only variables with 1
or more categorical levels that were statistically signiﬁcant
in the model construction sample were presented in the
ﬁnal models.
All statistical tests were 2-sided, with P ≤ 0.05 reﬂecting
statistical signiﬁcance. Statistical analyses were performed
with SAS, version 9.2 (SAS Institute, Inc., Cary, North
Carolina).
RESULTS
In the present study, black and white participants were
similar in age, but black participants included a higher per-
centage of women and residents of lower latitudes (i.e.,
closer to the equator) (Table 2). Figure 1 illustrates the un-
adjusted distribution of circulating 25(OH)D levels by
season of blood draw in the total study population. In both
whites (Figure 1A) and blacks (Figure 1B), the highest
Table 3. Distribution of Participant Characteristicsa by Circulating 25-Hydroxyvitamin D Category, US Radiologic
Technologists’ Study, 2008–2009
Characteristic No. ofParticipants
Circulating 25(OH)D Level
<25
(n = 81)
25 to <50
(n = 352)
50 to <75
(n = 499)
75 to <100
(n = 348)
≥100
(n = 220)
Age at blood draw,
yearsb
<60 704 6.0 25.3 34.9 22.0 11.8
≥60 796 4.9 21.9 31.8 24.3 17.2
Sex
Women 863 6.5 24.0 29.6 24.6 15.4
Men 637 3.9 22.8 38.3 21.4 13.7
Race
Black 646 9.0 31.9 29.4 17.5 12.2
White 842 2.4 17.0 36.0 27.9 16.8
Season of blood draw
Winter 476 6.3 27.3 31.9 22.7 11.8
Spring 347 4.6 24.8 32.9 22.5 15.3
Summer 271 5.5 17.0 36.2 24.0 17.3
Fall 406 4.9 22.2 33.3 23.9 15.8
Body mass indexc
<25 338 3.6 14.8 29.3 30.8 21.6
25 to <30 588 4.9 22.3 35.4 21.9 15.5
30 to <35 274 4.7 30.7 35.0 19.7 9.9
≥35 210 11.0 32.4 29.5 17.1 10.0
Latituded
<35° 445 5.8 25.6 33.3 22.5 12.8
35°–42° 776 5.5 23.6 32.6 22.4 15.9
>42° 279 4.3 19.7 35.1 26.5 14.3
Quintile of mean UVR
exposuree
1 300 4.7 27.0 34.7 20.0 13.7
2 299 6.0 26.1 31.1 23.8 13.0
3 301 7.3 31.1 33.2 25.9 13.6
4 300 4.0 23.0 33.7 22.7 16.7
5 300 5.0 21.3 33.7 23.7 16.3
Table continues
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mean 25(OH)D concentrations occurred in summer in the
northern part of the United states, that is, in latitudes at or
above 35°. The distribution of study participant characteris-
tics by categories of 25(OH)D status is shown in Table 3.
In the overall population, many single factors were asso-
ciated with 25(OH)D levels, such as age, race, season of
blood draw, BMI, milk intake, dietary intake (borderline
statistically signiﬁcant), supplement intake, and several in-
dicators of UVR exposure, including high levels of mean
UVR, number of hours outdoors (overall hours outdoors;
hours outdoors 10 AM–2 PM (borderline statistically
signiﬁcant); 8 AM–10 AM combined with 2 PM–5 PM),
physically active hours outdoors, certain UVR protective
behaviors (i.e., wearing a hat, long sleeves, or long pants,
standing in shade, wearing sunscreen and sunscreen protec-
tion factor), tanning bed use, and tan level (Web Table 1,
available at http://aje.oxfordjournals.org/). However, age,
sex, and race together accounted for only 6% of the 25(OH)D
variability, and other factors generally explained little of
the 25(OH)D variability, with the exception of supplemen-
tation with vitamin D, which explained another 15% in var-
iability. Sex, latitude, days in the sun away from residence,
Table 3. Continued
Characteristic No. ofParticipants
Circulating 25(OH)D Level
<25
(n = 81)
25 to <50
(n = 352)
50 to <75
(n = 499)
75 to <100
(n = 348)
≥100
(n = 220)
Quintile of mean UVR
exposuref (only
whites)
1 197 3.1 21.3 36.6 22.3 13.7
2 186 1.6 12.0 32.3 29.6 15.6
3 165 4.9 14.6 33.9 30.9 15.8
4 162 1.2 14.8 37.7 25.9 20.4
5 132 0.8 10.6 36.4 32.6 19.7
Time spent outdoors,
hours/day
<0.25 198 6.6 26.8 27.8 22.2 16.7
0.25–0.5 285 8.4 22.1 34.7 21.8 13.0
0.5–1 333 5.7 25.5 32.1 21.3 15.3
1–2 353 4.3 23.8 36.0 22.4 13.6
≥2 268 2.6 20.2 32.1 30.6 14.6
Time spent being
physically active
outdoors
<1.7 hours/week 619 7.1 27.3 32.5 18.7 14.4
≥1.7 hours/week 658 3.7 19.9 34.5 27.2 14.7
Wear long sleeves
Never 354 2.6 17.4 35.2 27.0 17.9
Rarely 266 4.5 20.3 33.1 26.3 15.8
Sometimes 313 4.8 21.4 37.4 24.3 12.1
Usually 202 6.9 26.7 31.7 21.8 12.9
Almost always 338 6.2 23.1 34.6 20.4 15.7
Use sun protection
factor
Never 791 6.0 25.6 34.9 20.5 13.0
Rarely 262 6.1 19.5 37.8 22.1 14.5
Sometimes 151 5.3 19.2 31.1 30.5 13.9
Usually 129 0 14.0 34.1 30.2 21.7
Almost always 137 4.4 19.7 28.5 29.9 17.5
Dietary vitamin D
intake, IU/dayg
<201.1 741 6.6 24.6 32.1 22.9 13.8
≥201.1 741 4.3 22.1 34.3 23.8 15.5
Table continues
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early morning and evening hours outside, indoor hours phys-
ically active, complexion (beyond that signiﬁed by race),
smoking status, current hormone replacement therapy use,
and inﬂammatory bowel disease were not related to 25(OH)D
levels.
Findings for whites were similar to those for the total
population (Web Table 1). For blacks, sun exposure vari-
ables (e.g., time outdoors, ambient UVR exposure, and sun
protective behaviors) were generally not related to vitamin
D levels. The determinants for men were similar to those
for the overall population, whereas for women, UVR expo-
sure variables explained little 25(OH)D variability.
Winter samples had the greatest number of signiﬁcant
determinants, particularly for UVR- related factors (Web
Table 2). Neither hours outdoors nor most sun protective
factors were signiﬁcantly predictive of 25(OH)D in summer
or fall.
In the stepwise regression analyses, factors that were
most strongly associated with higher circulating 25(OH)D
levels in the overall population were increased age, summer
and fall blood collection (compared with winter collection),
hours outdoors being physically active, and vitamin D sup-
plement intake level (Table 4). Factors most strongly
related to lower 25(OH)D were race (black compared with
white) and BMI above 25. These factors combined ac-
counted for 25% of the 25(OH)D variability in the overall
population.
Factors most strongly associated with 25(OH)D levels in
whites included season of blood collection, ambient UVR
exposure, BMI, hours outside being physically active, and
supplement intake (Table 4). In blacks, only age and sup-
plement use were associated with 25(OH)D levels. In
women, only race and vitamin D supplement level signiﬁ-
cantly predicted 25(OH)D levels, whereas in men, age,
race, season, ambient UVR level, BMI, hours outside phys-
ically active, and level of supplement use signiﬁcantly pre-
dicted circulating 25(OH)D levels. The R2 values varied in
subgroups between 0.23 (whites) and 0.30 (men).
When stratiﬁed by season, race was signiﬁcantly associ-
ated with 25(OH)D only in summer and fall (Web
Table 3. Continued
Characteristic No. ofParticipants
Circulating 25(OH)D Level
<25
(n = 81)
25 to <50
(n = 352)
50 to <75
(n = 499)
75 to <100
(n = 348)
≥100
(n = 220)
Supplement intake,
IU/dayh
<400 438 10.7 40.4 31.3 12.8 4.8
≥400 774 2.3 16.4 34.8 27.8 18.7
Tan leveli
Same 427 7.7 23.7 31.9 23.2 13.6
Slightly darker 631 4.1 24.9 33.6 22.5 14.9
Moderately darker 279 5.0 20.8 34.4 26.5 13.3
Much darker 80 3.8 17.5 31.3 22.5 25.0
Redder 9 0 22.2 33.3 11.1 33.3
Current smoker
Yes 141 8.5 31.9 24.1 21.3 14.2
No 1,309 5.0 22.6 33.8 23.5 15.1
Current HRT use
(women only)
Yes 120 4.2 22.5 30.0 27.5 15.8
No 342 5.0 19.3 29.5 27.2 19.0
Abbreviations: 25(OH)D, 25-hydroxyvitamin D; HRT, hormone replacement therapy; UVR, ultraviolet radiation.
a Characteristics of respondents based on the 30 days before survey response. Totals do not add up to 1,500 if
there are missing responses.
b Age at time of blood collection.
c Weight (kg)/height (m)2.
d At the place of residence.
e Mean ambient UVR (based on erythemal dose) at residence at month of blood collection averaged from 1978
to 1993. The UVR variable combines whites and blacks in the study. Quintile 1 was lowest; quintile 5 was highest.
f The UVR quintiles are presented for whites alone. There was little variation across 25(OH)D categories by
UVR quintile in blacks, and the results are not presented here.
g Sum of international units from dietary vitamin D sources (salmon, tuna, fortified cereal, milk, eggs, margarine,
and fortified juice). Median = 201.1 IU.
h Sum of international units of vitamin D from multivitamins, vitamin D supplements, and cod liver oil.
i Comparing the skin color on back of hand to the inside of upper arm.
186 Freedman et al.
Am J Epidemiol. 2013;177(2):180–192
Table 3). Supplement intake was associated with 25(OH)D
in every season. The R2 values by season ranged from 0.20
in the spring to 0.29 in the winter.
DISCUSSION
To our knowledge, this is the ﬁrst large nationwide US
study to examine the determinants of 25(OH)D levels by
assessing detailed personal UVR and other exposures in the
period just before blood collection in both black and white
participants. Despite the detailed information collected on a
wide variety of potential determinants of circulating 25(OH)D,
our ability to explain circulating 25(OH)D levels was
modest, accounting for 25% of the variance in 25(OH)D in
the total population and similar percentages within racial
and sex subgroups. Other studies have had comparably
limited ability to explain 25(OH)D variance (14, 17, 29) in
part because of the lack of information on individual sun
exposure (27), whereas our study speciﬁcally evaluated
UVR-related factors. Moreover, one study with a relatively
high overall R2 of 0.42 (16) could attribute only about 3%
of variability to individual sun exposure factors.
Age, sex, and race together explained only 6 percent of
the variability in the overall study population. Although in-
creasing age was positively related to 25(OH)D levels,
other studies have reported mixed results for age (12, 15,
16, 18, 22, 27, 32, 50). In experimental studies, it has been
suggested that aging skin has a declining capacity to pro-
duce vitamin D (51, 52), but this limitation may be concen-
trated in older ages, for example, in persons older than 69
years of age in the study by Need et al. (53). The positive
associations with age seen in the present study may reﬂect the
age distribution of USRT participants, who were generally
not elderly. Sex did not play a role in accounting for 25(OH)D
levels in the total population or within subgroups, a result
common to some studies (16, 32) but not others (20, 25).
Race (black compared with white) was signiﬁcantly asso-
ciated with lower 25(OH)D levels in both men and women.
Race has been consistently related to circulating 25(OH)D
levels (8, 16, 25, 27, 29, 30, 32). Some of the racial disparity
reﬂects differences in skin melanin content, as dark skin has
a higher threshold for synthesizing detectable pre-vitamin D3
(54). In the present study, however, race accounted for less
than 6% of the 25(OH)D variability. The relatively low con-
tribution of race to 25(OH)D variability in this study may
partly reﬂect the shared behavioral patterns in an occupation-
al cohort of people who may have fairly similar lifestyles.
Shared behavioral patterns may also contribute to the simi-
larity in levels of 25(OH)D in white and black participants.
In the present study, 45% of white participants had
25(OH)D levels of 75 nmol/L of higher compared with 30%
of black participants, whereas in the Adventist Health Study-
2 (16), 52% of whites compared with 16% of blacks had
levels of 75 nmol/L or higher.
BMI was a signiﬁcant inverse determinant of 25(OH)D
level in the total population, although not in women or
blacks. The inverse association with BMI has been seen in
other studies (8, 12, 16, 25), as has the absence of a relation
with BMI (or body fat) observed in many (16, 25, 31, 55),
but not all (10), studies of blacks. The inverse association
with higher BMI may reﬂect reduced sun exposure due to
less time outdoors, more clothing, and/or vitamin D seques-
tering in fat (56). It has been hypothesized that the limited
association between BMI and 25(OH)D levels in blacks (at
least for women) may reﬂect a higher proportion of lean
body mass in black, compared with white, women for any
particular BMI (31, 57).
We saw no signiﬁcant contribution to 25(OH)D from
dietary sources in the ﬁnal models for the overall popula-
tion or subgroups, although some studies have shown a mo-
dest positive association (15, 16, 23, 25). In our study, the
strongest determinant, including for subgroups, was vitamin
D supplement intake. This likely reﬂects the high vitamin D
intake in the USRT participants, a group of health care
workers, who reported a mean daily supplement intake of
523 IU in whites and 453 IU in blacks (with 14% and 11%,
respectively, taking ≥1,000 IU/day). In contrast, one recent
study in the United States reported a mean vitamin D in-
take of 252 IU in whites and 200 IU in blacks (16), and
another showed 400 IU or less taken by about 90% of par-
ticipants (27).
As noted earlier, UVR exposure comprised ambient and
personal UVR exposure factors, including hours outdoors,
which varied by duration and time of day, susceptibility
factors (e.g., complexion), and protective behaviors. Despite
surveying these factors, UVR exposure played a minor role
in predicting 25(OH)D levels.
Notably, latitude played no role in explaining 25(OH)D
levels, whereas mean erythemal dose for the month of
blood draw only modestly explained variation for men and
whites. Erythemal dose may not sufﬁciently represent the
ultraviolet B wavelengths relevant to 25(OH)D production.
Also, sun avoidance may be so commonplace (mean time
outdoors per week was less than 1.5 hours (Table 2)) that
geographic solar irradiance is not particularly relevant to
personal 25(OH)D dose.
The fact that the number of hours outdoors failed to
explain much of the variability in 25(OH)D levels may
reﬂect that cutaneous vitamin D synthesis reaches saturation
levels quickly (58), which would suggest that repeated
outdoor spans are more relevant, although difﬁcult to esti-
mate. Other studies with personal UVR exposure informa-
tion have also found that individual UVR exposure factors
did not substantially improve explanatory power (12, 14,
16, 23).
That the number of hours being physically active out-
doors was a stronger predictor than hours outside also sug-
gests that the character of outside time may be important.
Some have suggested that exercise itself, independent of
outdoor time, may affect vitamin D levels (34, 59);
however, our ﬁnding that indoor physical activity was unre-
lated to vitamin D levels does not support this hypothesis.
For blacks, UVR factors played no signiﬁcant role in
25(OH)D levels. Personal UVR exposure also was unrelated
in blacks in 2 other US studies in which determinants of
vitamin D in both blacks and whites were examined (10, 16).
Notably, Chan et al. (16) did see a signiﬁcant role for season
and erythemal zone based on ultraviolet index maps in pre-
dicting 25(OH)D in black participants, although the contribu-
tion of erythemal zone was small in both whites and blacks.
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Table 4. Predictors of Circulating 25-Hydroxyvitamin D Levelsa, Overall and by Sex and Race, US Radiologic Technologists’ Study, 2008–2009
Characteristic
Overall (R2 = 0.25) Men (R2 = 0.30) Women (R2 = 0.27)
No. of Participants β Coefficient (SE) P Value No. ofParticipants
β Coefficient
(SE) P Value No. of Participants
β Coefficient
(SE) P Value
Ageb 1,037 0.21 (0.10) 0.03 459 0.40 (0.14) 0.004 663 0.13 (0.13) 0.30
Sex
Women 578 Referent
Men 459 1.99 (1.77) 0.26
Race
White 611 Referent 305 Referent 344 Referent
Black 419 −8.91 (1.75) <0.0001 148 −11.51 (2.66) <0.0001 317 −7.94 (2.15) 0.0002
Other 7 −17.19 (10.08) 0.09 6 −22.63 (10.74) 0.04 2 3.88 (19.38) 0.84
Season
Winter 338 Referent 145 Referent
Spring 231 2.24 (2.27) 0.32 91 −5.74 (4.71) 0.22
Summer 185 10.09 (2.45) <0.0001 82 2.59 (4.78) 0.59
Fall 283 5.32 (2.13) 0.01 141 8.11 (3.17) 0.01
Quintile of mean UVR exposurec
1 87 Referent
2 98 6.10 (3.85) 0.11
3 99 5.38 (4.08) 0.19
4 102 17.53 (4.83) 0.0003
5 73 12.99 (5.86) 0.03
BMId
<25 244 Referent 91 Referent
25 to <30 411 −5.67 (2.15) 0.009 201 −8.08 (3.24) 0.01
30 to <35 197 −9.30 (2.56) 0.003 96 −12.72 (3.80) 0.0009
≥35 164 −12.93 (2.73) <0.0001 58 −20.93 (4.34) <0.0001
Time spent being physically active
outdoors, hours/week
1,037 0.38 (0.16) 0.02 459 0.50 (0.20) 0.01
Wears long sleeves
Not outside 22 Referent
Never 67 11.93 (6.35) 0.06
Rarely 106 5.40 (5.90) 0.36
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Table 4. Continued
Characteristic
Overall (R2 = 0.25) Men (R2 = 0.30) Women (R2 = 0.27)
No. of Participants β Coefficient (SE) P Value No. ofParticipants
β Coefficient
(SE) P Value No. of Participants
β Coefficient
(SE) P Value
Sometimes 93 −1.29 (5.87) 0.83
Usually 55 3.70 (6.24) 0.55
Almost always 113 2.09 (5.69) 0.71
Vitamin D supplement intake, IU/day 1,037 0.02 (0.002) <0.0001 459 0.02 (0.002) <0.0001 663 0.03 (0.002) <0.0001
Blacks (R2 = 0.26) Whites (R2 = 0.23)
No. of
Participants β Coefficient (SE) P Value No. of Participants β Coefficient (SE) P Value
Ageb 498 0.41 (0.17) 0.02 611 0.09 (0.11) 0.43
Sex
Women 317 Referent 306 Referent
Men 181 4.53 (2.74) 0.10 305 2.80 (2.27) 0.22
Race
White
Black
Other
Season
Winter 226 Referent
Spring 133 −6.98 (3.86) 0.07
Summer 84 2.66 (4.16) 0.52
Fall 168 8.32 (2.62) 0.002
Quintile of mean UVR exposurec
1 142 Referent
2 142 6.45 (3.02) 0.03
3 116 5.52 (3.43) 0.11
4 118 18.69 (4.14) <0.0001
5 93 15.03 (4.77) 0.002
BMId
<25 170 Referent
25 to <30 250 −9.55 (2.60) 0.0003
30 to <35 106 −16.74 (3.21) <0.0001
≥35 73 −16.63 (3.65) <0.0001
Time spent being physically active
outdoors, hours/week
611 0.44 (0.19) 0.02
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Similarly, in a study of elderly whites and blacks, Shea et al.
(36) found that time walking, a surrogate for outdoor time,
was not related to 25(OH)D levels in blacks.
Strengths of our study include the nationwide distribu-
tion of participants, substantial numbers of both whites
and blacks, and the detailed questionnaire covering person-
al/ambient UVR and other potential determinants close to
the date of blood collection. In addition, all assays were
processed in a laboratory with good quality control. More-
over, as Millen et al. (27) indicated, few studies have vali-
dated their models by comparing predicted values with
actual measures. Notably, the Pearson correlation coefﬁ-
cient of 0.50 (P < 0.0001) in our validation sample is
similar to the correlation (r = 0.45) reported by Millen
et al. (27).
Our study is limited by its reliance on self-administered
questionnaires. Possibly, 25(OH)D predictability could be
improved with more sophisticated measures of adiposity,
skin pigmentation, and personal exposure (using UVR do-
simeters). Genetic variants may also affect 25(OH)D levels
(37, 60). These areas for potential improvement, however,
would be inapplicable to deriving questionnaire-based sur-
rogates for 25(OH)D.
In addition, data from US radiologic technologists may
not be generalizable to other populations (e.g., persons with
lower incomes) with different behavior patterns regarding
outdoors activities and supplement use, for example. Also,
the low response rate in the USRT supplementary group of
blacks (26%) could inﬂuence the ﬁndings if respondents
differed from the larger USRT black population (e.g., in
terms of socioeconomic status, which could affect vitamin
D supplement use patterns.).
Our study of 25(OH)D determinants in a large study
group with detailed information on personal UVR expo-
sures, as well as demographic, lifestyle, and dietary expo-
sures, illustrates the difﬁculty of predicting circulating
vitamin D levels. We could explain only 23% of the 25(OH)D
variability in whites and only 26% in blacks. The survey
instrument focused on UVR-related behavior, thus suggest-
ing the difﬁculty in identifying vitamin D-related UVR be-
havioral factors. Our modest ability to explain 25(OH)D
variability further suggests that surveys alone are unlikely
to provide adequate surrogates for vitamin D levels. These
results also raise questions about ﬁndings in which surro-
gates for vitamin D levels (e.g., latitude, diet) have been
interpreted to inform our understanding of vitamin D and
disease. Observed relations between surrogates for vitamin
D and disease outcomes may provide more insights about
the surrogates than about vitamin D.
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